/Mckesson%20Corporation%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
Irving, Texas-based McKesson Corporation (MCK) provides healthcare services in the U.S. and internationally. With a market cap of $65.7 billion, McKesson operates through the U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International segments. It is expected to announce its Q1 earnings for 2025 after the market closes on Wednesday, Nov. 6.
Ahead of the event analysts expect McKesson to report a profit of $6.99 per share, up 12.2% from $6.23 per share reported in the year-ago quarter. The company has surpassed Wall Street’s adjusted EPS earnings thrice over the past four quarters while missing on another occasion. Its adjusted EPS for the last reported quarter grew 8.4% year-over-year to $7.88, while surpassing the consensus estimates by 10.1%.